Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

LUZE Fit Intensity may be harmful due to hidden ingredient

15 September 2026 · By · Wire by Fusion42

Published

15 September 2026

Topic

opportunities

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at fda.gov →

◆ Verified

Fusion42 · 16 September 2026 · Fusion42 review

The FDA has warned that LUZE Fit Intensity, marketed for weight loss, contains the controlled substance sibutramine, which is not disclosed on the label and poses serious health risks such as elevated blood pressure and heart rate. The product may cause life-threatening interactions with other medications and should not be used.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

Your weight loss product faces new scrutiny after FDA found dangerous hidden substances. Avoid unverified supplements or risk regulatory trouble and customer harm.

◆ Coverage

1 source · 15 Sep 2026

◆ Related on Wire

◆ Topics

HealthFDA-warningweight-losshidden-ingredientsibutramineproduct-safety